High frequency and founder effect of the CYP3A4*20 loss-of-function allele in the Spanish population classifies CYP3A4 as a polymorphic enzyme
María Apellániz-Ruiz(Navarrabiomed), Cristina Rodríguez‐Antona(Instituto de Salud Carlos III), Aguirre A. de Cubas(Medical University of South Carolina), Ahmed Rebaï(Centre of Biotechnology of Sfax), Adrián LLerena(Instituto de Salud Carlos III), Patricia Taboada-Echalar(University of Chile), Manuela Grazina(University of Coimbra), Lara M. Munín Sánchez(Spanish National Cancer Research Centre), Giuseppe Opocher(University of Padua), Graciela Moya(Pontificia Universidad Católica Argentina), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Soumaya Triki(Centre of Biotechnology of Sfax), Veronika Mančíková(Centro de Biología Molecular Severo Ochoa), Ãngel Carracedo(Center for Research in Molecular Medicine and Chronic Diseases), Lucía Inglada‐Pérez(Spanish National Cancer Research Centre), Mahmood Rasool(King Abdulaziz University), Alberto Cascón(Spanish National Cancer Research Centre), Iñaki Comino‐Méndez(Breast Cancer Now), María Currás-Freixes(Spanish National Cancer Research Centre), M.E.G. Naranjo(Universidad de Extremadura), Magnus Ingelman‐Sundberg(Karolinska Institutet)
Cited by 67
Related Papers
Metabolic gene polymorphism frequencies in control populations.
|PubMed|2001|847
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
|Cell Reports|2018|818
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
|Cancer Cell|2017|791